161 related articles for article (PubMed ID: 26608859)
1. [Efficacy of disease modifying anti-rheumatic drugs on bone destruction in rheumatoid arthritis].
Tsuji H; Mimori T
Clin Calcium; 2015 Dec; 25(12):1835-42. PubMed ID: 26608859
[TBL] [Abstract][Full Text] [Related]
2. [Control of bone and cartilage lesions in rheumatoid arthritis with TNF inhibitors].
Amano K
Clin Calcium; 2015 Dec; 25(12):1843-50. PubMed ID: 26608860
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
Castrejón I; Gibson KA; Pincus T
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
[TBL] [Abstract][Full Text] [Related]
4. [ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs].
Ichikawa N; Yamanaka H
Clin Calcium; 2012 Feb; 22(2):215-21. PubMed ID: 22298075
[TBL] [Abstract][Full Text] [Related]
5. Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.
Haibel H; Specker C
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S159-63. PubMed ID: 19822065
[TBL] [Abstract][Full Text] [Related]
6. [Combination therapy of disease-modifying antirheumatic drugs(DMARDs) in rheumatoid arthritis].
Kobayashi S; Kanai Y
Nihon Rinsho; 2002 Dec; 60(12):2351-6. PubMed ID: 12510361
[TBL] [Abstract][Full Text] [Related]
7. The use of conventional disease-modifying anti-rheumatic drugs in established RA.
Jurgens MS; Jacobs JW; Bijlsma JW
Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):523-33. PubMed ID: 22137922
[TBL] [Abstract][Full Text] [Related]
8. TNF inhibitors in the treatment of arthritis.
Lorenz HM
Curr Opin Investig Drugs; 2000 Oct; 1(2):188-93. PubMed ID: 11249572
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of bone destruction in rheumatoid arthritis and perspectives of the treatment].
Koyama T; Tanaka S
Clin Calcium; 2016 May; 26(5):735-41. PubMed ID: 27117620
[TBL] [Abstract][Full Text] [Related]
10. Overview of combination second-line or disease-modifying antirheumatic drug therapy in rheumatoid arthritis.
Williams HJ
Br J Rheumatol; 1995 Nov; 34 Suppl 2():96-9. PubMed ID: 8535657
[TBL] [Abstract][Full Text] [Related]
11. Disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid disease.
Subhash C; Agarwal AK; Rewari BB; Sangla KS; Vijay A
J Assoc Physicians India; 1995 Mar; 43(3):232-3. PubMed ID: 11256928
[No Abstract] [Full Text] [Related]
12. Are biologics more effective than classical disease-modifying antirheumatic drugs?
Nurmohamed MT; Dijkmans BA
Arthritis Res Ther; 2008; 10(5):118. PubMed ID: 18828888
[TBL] [Abstract][Full Text] [Related]
13. The role of anti-malarials in rheumatoid arthritis--the American experience.
Khraishi MM; Singh G
Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
[TBL] [Abstract][Full Text] [Related]
14. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.
Fleischmann R; Koenig AS; Szumski A; Nab HW; Marshall L; Bananis E
Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
16. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
Sesin CA; Bingham CO
Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
[TBL] [Abstract][Full Text] [Related]
17. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
[TBL] [Abstract][Full Text] [Related]
18. The effects of disease modifying anti-rheumatic drugs on osteoclastogenesis and bone destruction in rheumatoid arthritis.
Nanke Y; Yago T; Kotake S
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(6):493-500. PubMed ID: 22214810
[TBL] [Abstract][Full Text] [Related]
19. [DMARDs (disease-modifying antirheumatic drugs)].
Tanaka E; Yamanaka H
Nihon Rinsho; 2013 Jul; 71(7):1199-206. PubMed ID: 23961667
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis.
Fleischmann R
Expert Opin Drug Saf; 2003 Jul; 2(4):347-65. PubMed ID: 12904092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
